Table of Contents
Journal of Biomarkers
Volume 2016 (2016), Article ID 2198745, 5 pages
http://dx.doi.org/10.1155/2016/2198745
Research Article

The Diagnostic Value of Serum C-Reactive Protein for Identifying Pneumonia in Hospitalized Patients with Acute Respiratory Symptoms

Department of Internal Medicine, Arnau de Vilanova University Hospital, Biomedical Research Institute of Lleida Foundation Dr. Pifarré (IRBLleida), 25198 Lleida, Spain

Received 10 May 2016; Accepted 25 July 2016

Academic Editor: Mark Duncan

Copyright © 2016 Agustín Ruiz-González et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Jain, W. H. Self, and R. G. Wunderink, “Community-acquired pneumonia requiring hospitalization,” The New England Journal of Medicine, vol. 373, no. 24, pp. 415–427, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Metlay, W. N. Kapoor, and M. J. Fine, “Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination,” The Journal of the American Medical Association, vol. 278, no. 17, pp. 1440–1445, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. E. E. Walsh, A. J. Swinburne, K. L. Becker et al., “Can serum procalcitonin levels help interpret indeterminate chest radiographs in patients hospitalized with acute respiratory illness?” Journal of Hospital Medicine, vol. 8, no. 2, pp. 61–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. W. S. Lim, S. V. Baudouin, R. C. George et al., “British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009,” Thorax, vol. 64, supplement 3, pp. iii1–iii55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Blasi, M. Bocchino, F. Di Marco, L. Richeldi, and S. Aliberti, “The role of biomarkers in low respiratory tract infections,” European Journal of Internal Medicine, vol. 23, no. 5, pp. 429–435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Smith, B. J. Lipworth, I. A. Cree, E. M. Spiers, and J. H. Winter, “C-reactive protein: a clinical marker in community-acquired pneumonia,” Chest, vol. 108, no. 5, pp. 1288–1291, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. L.-O. Hansson, J. U. Hedlund, and A. B. Ortqvist, “Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 57, no. 2, pp. 111–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Castro-Guardiola, A. Armengou-Arxé, A.-L. Viejo-Rodríguez, G. Peñarroja-Matutano, and F. Garcia-Bragado, “Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emergency ward,” European Journal of Internal Medicine, vol. 11, no. 6, pp. 334–339, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Chalmers, A. Singanayagam, A. R. Akram et al., “Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis,” Thorax, vol. 65, no. 10, pp. 878–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Global Initiative for Chronic Obstructive Lung Disease, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease, 2015, http://www.goldcopd.it/materiale/2015/GOLD_Report_2015.pdf.
  11. M. Woodhead, F. Blasi, S. Ewig et al., “Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections,” Clinical Microbiology and Infection, vol. 17, supplement 6, pp. e1–e59, 2011. View at Google Scholar
  12. C. W. Yancy, M. Jessup, B. J. Bozkurt et al., “2013 ACCF/AHA Guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation, vol. 128, no. 16, pp. e240–e327, 2013. View at Publisher · View at Google Scholar
  13. R. Jaeschke, G. Guyatt, and D. Sackett, “User's guides to the medical literature: III: how to use an article about a diagnostic test,” Journal of the American Medical Association, vol. 271, pp. 703–707, 1994. View at Google Scholar
  14. B. Müller, S. Harbarth, D. Stolz et al., “Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia,” BMC Infectious Diseases, vol. 7, article 10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Bafadhel, T. W. Clark, C. Reid et al., “Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD,” Chest, vol. 139, no. 6, pp. 1410–1418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Heffner, S. A. Sahn, and L. K. Brown, “Multilevel likelihood ratios for identifying exudative pleural effusions,” Chest, vol. 121, no. 6, pp. 1916–1920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. Alba, Q. A. Truong, H. K. Gaggin et al., “Diagnostic and prognostic utility of procalcitonin in patients presenting to the emergency department with dyspnea,” American Journal of Medicine, vol. 129, pp. 96–110, 2016. View at Publisher · View at Google Scholar · View at Scopus